查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
女性用健康、美容補充品的全球市場:市場規模 - 各產品，各消費群組，各流通管道，各用途，各年齡層，各種價格，各地區展望，競爭策略，各市場區隔預測(～2032年)
市場調查報告書
商品編碼
1159573

女性用健康、美容補充品的全球市場:市場規模 - 各產品，各消費群組，各流通管道，各用途，各年齡層，各種價格，各地區展望，競爭策略，各市場區隔預測(～2032年)

Women Health and Beauty Supplements Market Size- By Product, By Consumer Group, By Distribution Channel, By Application, By Age Group, By Price- Regional Outlook, Competitive Strategies and Segment Forecasts to 2032
出版日期: | 出版商: SPER Market Research Pvt. Ltd. | 英文 242 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球女性用健康、美容補充品的市場規模，預計至2032年達到8,637萬美元，以4.12％的年複合成長率成長。

在維他命不足的所有年代的女性之間，對維他命A，B，C，E等追加維他命的需求高漲，成為部門的促進因素。為了對應這個需求增加，全球的企業投資新的維他命產品的研究開發。由於有健康意識的人們增加，帶來市場成長，喜歡出色口味和攝取便利性的老年人層的需求持續增加，也推動市場成長。

本報告提供全球女性用健康、美容補充品市場相關調查，市場動態，市場變數及預測，各產品、消費群組、流通管道、用途、年齡層、價格分佈、地區的市場分析，企業簡介等相關資訊。

目錄

第1章 簡介

  • 調查範圍
  • 市場區隔分析

第2章 調查手法

  • 調查資料來源
  • 市場規模的估計
  • 資料的三角測量

第3章 摘要整理

第4章 市場動態

  • 促進因素，阻礙因素，機會，課題的分析
    • 促進因素
    • 阻礙因素
    • 機會
    • 課題
  • 全球女性用健康、美容補充品市場的COVID-19影響

第5章 市場變數及預測

  • SWOT分析
    • 優勢
    • 弱點
    • 機會
    • 威脅
  • PESTEL分析
    • 政治形勢
    • 經濟形勢
    • 社會形勢
    • 技術形勢
    • 環境形勢
    • 法律上的形勢
  • 波特的五力分析
    • 供給企業談判力
    • 買方議價能力
    • 替代品的威脅
    • 新加入廠商的威脅
    • 競爭企業間的敵對關係
  • 熱圖分析

第6章 全球女性用健康、美容補充品市場:各產品，2019年～2032年(100萬美元)

  • 維生素和礦物質
  • 植物性
  • 蛋白質、氨基酸
  • Omega-3
  • 益生菌
  • 其他

第7章 全球女性用健康、美容補充品市場:各消費群組，2019年～2032年(100萬美元)

  • 產前產後
  • 經前症候群
  • 更年期障礙
  • 停經後
  • 其他

第8章 全球女性用健康、美容補充品市場:各流通管道，2019年～2032年(100萬美元)

  • 線上
    • 第三方的網站
    • 自家公司的網站
  • 離線
    • 專賣店
    • 大賣場、超級市場
    • 其他(獨立零售店等)

第9章 全球女性用健康、美容補充品市場:各用途，2019年～2032年(100萬美元)

  • 美容
    • 皮膚
    • 頭髮
    • 指甲
  • 女性用健康

第10章 全球女性用健康、美容補充品市場:各年齡層，2019年～2032年(100萬美元)

  • 15～30歲
  • 31～50歲
  • 51～70歲
  • 70歲以上

第11章 全球女性用健康、美容補充品市場:各種價格，2019年～2032年(100萬美元)

  • 低(25美元以下)
  • 中(26美元～80美元)
  • 高(80美元以上)

第12章 全球女性用健康、美容補充品市場:各地區，2019年～2032年(100萬美元)

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他的歐洲
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 其他的亞太地區
  • 南美
    • 巴西
    • 阿根廷
    • 其他的南美
  • 中東、非洲
    • 沙烏地阿拉伯王國
    • 阿拉伯聯合大公國
    • 其他的中東、非洲

第13章 企業簡介

  • Asahi Group Holdings, Ltd.
    • 企業概要
    • 財務預測
    • 產品概要
    • 最近的開發
  • Bayer AG
  • Bio Veda Action Research Co.
  • Blackmores
  • BY-HEALTH Co., Ltd.
  • Clinic Health Pvt. Ltd
  • Clinique Laboratories, LLC
  • FANCL Corp.
  • Femarelle
  • Garden of Life (Nestle)
  • GNC Holdings Inc.
  • Grape King Bio Ltd.
  • Guardian.in
  • Herbalife International of America Inc.
  • INJA WELLNESS LLP
  • Minimalist
  • Nature's Bounty Co.
  • Neemli
  • Nu Skin Enterprise, Inc.
  • Organic Harvest
  • OZiva
  • Pfizer Inc.
  • Pharmavite LLC
  • Revital Ltd.
  • Standard Foods Corp.
  • Suntory Holdings Ltd.
  • Swisse Wellness Pty. Ltd
  • Taisho Pharmaceutical Co. Ltd.
  • The Derma Co
  • The Himalaya Drug Company
  • The Nature's Bounty Co
  • Truebasics.com
  • USANA Health Sciences, Inc.
  • Vita Life Sciences
簡介目錄
Product Code: NUTR2201

Global Women Health and Beauty Supplements Market Overview:

According to SPER Market Research, the Global Women Health and Beauty Supplements Market is estimated to reach USD 86.37 million by 2032 with a CAGR of 4.12%.

A supplement is intended to complement the diet when used orally as a pill, capsule, tablet, or liquid. A supplement can offer nutrients that have been synthesized or taken from dietary sources, either alone or in combination. Disorders with fertility and other issues in women are brought on by dietary changes and insufficient nutritional intake. Numerous nutritional supplement items, including vitamins, minerals, enzymes, botanicals, proteins, omega-3 fatty acids, and probiotics, are sold on the market and are used to address various health ailments in women as well as problems with their appearance related to their skin, hair, and nails.

The sector is being driven by the rising demand for additional vitamins, such as vitamins A, B, C, and E, among women of all ages who suffer from vitamin deficiencies. In order to fulfill the rising demand, businesses all around the world are also investing in the research and development of new vitamin products. To make the user seem younger and more attractive, anti-aging creams, serums, moisturising creams, and other items are utilised. They shield the skin from UV radiation and keep the pH level at a healthy level. These are some of the main forces influencing the market for women's health and beauty products.

Salicylic acid and tea tree oil are now used in face washes and other beauty products to treat acne, scars, cystic acne, and other skin issues. This helps to cleanse the skin's pores and maintains the skin looking clean and healthy. Because of these advantages, there will probably be more demand for beauty products in the future. Women who have gone through menopause are more susceptible to conditions including anemia, osteoporosis, osteoarthritis (OA), fibromyalgia, obesity, and depression. It is predicted that new product advancements that reduce the risk of postmenopausal health issues including osteoporosis would increase product acceptability.

According to WHO research, 73% of postmenopausal women have hot flashes, which increase their need on certain drugs along with sleep difficulties and exhaustion. Growth in the market for women's health and beauty supplements is driven by an increase in the number of health-conscious people. In addition, the market is growing because of an increase in demand from the older population, who prefer the superior flavour and convenience of consumption. Increased use of probiotic beverages has a beneficial effect on the market expansion. Additionally, it is anticipated that increased R&D for the creation of superior health supplements for a range of nutritional inadequacies would fuel market expansion during the projection period. The market for women's health and beauty supplements is anticipated to develop, although strict government restrictions and regulations may impede this.

Impact of COVID-19 on the Global Women Health and Beauty Supplements Market

The pandemic has a beneficial effect on the market since most nations implemented lockdown measures to stop the virus' spread. Companies found it challenging to get their products on the market for widespread consumer use at the start of the spread. Additionally, the shutdown of industrial activities significantly disrupted the supply chain for the production of nutritional goods. Additionally, customers only paid attention to necessities like food and drink. However, businesses have restarted their procedures to meet the market need for items as lockdowns have eased and COVID-19 instances have decreased. The immune system has been proven to benefit from dietary supplements, according to study. The demand for dietary supplements has significantly expanded as a result of this new trend. The COVID-19 epidemic has also raised consumer awareness of the importance of taking care of one's own physical, mental, and emotional needs. As a result, the use of health and beauty supplements has expanded.

Scope of the Report:

Market size available for years 2019-2032

Base year considered 2021

Forecast period 2022-2032

Segments covered By Product, By Consumer Group, By Distribution Channel, By Application, By Age Group, By Price

Geographies covered: North America, Europe, Asia Pacific, Latin America, Middle East and Africa

Companies Covered Asahi Group Holdings, Ltd., Bayer AG, Bio Veda Action Research Co., Blackmores, BY-HEALTH Co., Ltd., Clinic Health Pvt. Ltd, Clinique Laboratories, LLC, FANCL Corp., Femarelle, Garden of Life (Nestle), GNC Holdings Inc., Grape King Bio Ltd., Guardian.in, Herbalife International of America Inc., INJA WELLNESS LLP, Minimalist, Nature's Bounty Co., Neemli, Nu Skin Enterprise, Inc., Organic Harvest, OZiva, Pfizer Inc., Pharmavite LLC, Revital Ltd., Standard Foods Corp., Suntory Holdings Ltd., Swisse Wellness Pty. Ltd, Taisho Pharmaceutical Co. Ltd., The Derma Co, The Himalaya Drug Company, The Nature's Bounty Co, Truebasics.com, USANA Health Sciences, Inc., Vita Life Sciences.

Global Women Health and Beauty Supplements Market Segmentation:

By Product: Based on the Product, Global Women Health and Beauty Supplements Market is segmented as; Vitamins & Minerals, Botanical, Proteins & Amino Acids, Omega-3, Probiotics and Others.

By Consumer Group: Based on the Consumer Group, Global Women Health and Beauty Supplements Market is segmented as; Pre & postnatal, Premenstrual syndrome, Perimenopause, Postmenopause and Others.

By Distribution Channel: Based on the Distribution Channel, Global Women Health and Beauty Supplements Market is segmented as; Online (Third Party Website, Company Owned Website), Offline (Specialty Stores, Hypermarkets and Supermarkets, Others).

By Application: Based on the Application, Global Women Health and Beauty Supplements Market is segmented as; Beauty (Skin, Hair, Nail) and Women Health.

By Age Group: Based on the Age Group, Global Women Health and Beauty Supplements Market is segmented as; Age 15 - 30, Age 31 - 50, Age 51 - 70, Above 70 years.

By Price: Based on the Price, Global Women Health and Beauty Supplements Market is segmented as; Low (US$ 25 and below), Medium (US$ 26 - US$ 80) and High (US$ 80 and above).

By Region: The market for women's health and beauty supplements is anticipated to grow most rapidly in North America, then Europe. In addition, Asia-Pacific is anticipated to have the largest market development potential during the projection period due to the region's expanding patient base and rising healthcare awareness. Additional factors contributing to the Asia-Pacific market's growth include rising per capita income and regional governments' efforts to improve healthcare standards. The market for women's health and beauty supplements is anticipated to develop, although strict government restrictions and regulations may impede this.

Table of Contents

1. Introduction

  • 1.1. Scope of the report
  • 1.2. Market segment analysis

2. Research Methodology

  • 2.1 Research data source
    • 2.1.1 Secondary data
    • 2.1.2 Primary data
    • 2.1.3 SPER's internal database
    • 2.1.4 Premium insight from KOL's
  • 2.2 Market size estimation
    • 2.2.1 Top-down and Bottom-up approach
  • 2.3 Data triangulation

3. Executive Summary

4. Market Dynamics

  • 4.1. Driver, Restraint, Opportunity and Challenges analysis
    • 4.1.1 Drivers
    • 4.1.2 Restraints
    • 4.1.3 Opportunities
    • 4.1.4 Challenges
  • 4.2. COVID-19 Impacts of the Global Women Health and Beauty Supplements Market

5. Market variables and outlook

  • 5.1. SWOT analysis
    • 5.1.1 Strengths
    • 5.1.2 Weaknesses
    • 5.1.3 Opportunities
    • 5.1.4 Threats
  • 5.2. PESTEL analysis
    • 5.2.1 Political landscape
    • 5.2.2 Economic landscape
    • 5.2.3 Social landscape
    • 5.2.4 Technological landscape
    • 5.2.5 Environmental landscape
    • 5.2.6 Legal landscape
  • 5.3. PORTER'S five forces analysis
    • 5.3.1 Bargaining power of suppliers
    • 5.3.2 Bargaining power of Buyers
    • 5.3.3 Threat of Substitute
    • 5.3.4 Threat of new entrant
    • 5.3.5 Competitive rivalry
  • 5.4. Heat map analysis

6. Global Women Health and Beauty Supplements Market, By Product, 2019-2032 (USD Million)

  • 6.1. Vitamins & Minerals
  • 6.2. Botanical
  • 6.3. Proteins & Amino Acids
  • 6.4. Omega-3
  • 6.5. Probiotics
  • 6.6. Others

7. Global Women Health and Beauty Supplements Market, By Consumer Group, 2019-2032 (USD Million)

  • 7.1. Pre & postnatal
  • 7.2. Premenstrual syndrome
  • 7.3. Perimenopause
  • 7.4. Postmenopause
  • 7.5. Others

8. Global Women Health and Beauty Supplements Market, By Distribution Channel, 2019-2032 (USD Million)

  • 8.1 Online
    • 8.1.1 Third Party Website
    • 8.1.2 Company Owned Website
  • 8.2 Offline
    • 8.2.1 Specialty Stores
    • 8.2.2 Hypermarkets and Supermarkets
    • 8.2.3 Others (Independent Retail Stores, etc.)

9. Global Women Health and Beauty Supplements Market, By Application, 2019-2032 (USD Million)

  • 9.1 Beauty
    • 9.1.1 Skin
    • 9.1.2 Hair
    • 9.1.3 Nail
  • 9.2 Women Health

10. Global Women Health and Beauty Supplements Market, By Age Group, 2019-2032 (USD Million)

  • 10.1 Age 15 - 30
  • 10.2 Age 31 - 50
  • 10.3 Age 51 - 70
  • 10.4 Above 70 years

11. Global Women Health and Beauty Supplements Market, By Price 2019-2032 (USD Million)

  • 11.1. Low (US$ 25 and below)
  • 11.2. Medium (US$ 26 - US$ 80)
  • 11.3. High (US$ 80 and above)

12. Global Women Health and Beauty Supplements Market, By Region, 2019-2032 (USD Million)

  • 12.1 North America
    • 12.1.1 United States
    • 12.1.2 Canada
    • 12.1.3 Mexico
  • 12.2 Europe
    • 12.2.1 Germany
    • 12.2.2 United Kingdom
    • 12.2.3 France
    • 12.2.4 Italy
    • 12.2.5 Spain
    • 12.2.6 Rest of Europe
  • 12.3 Asia-Pacific
    • 12.3.1 China
    • 12.3.2 Japan
    • 12.3.3 India
    • 12.3.4 Australia
    • 12.3.5 South Korea
    • 12.3.6 Rest of Asia-Pacific
  • 12.4 South America
    • 12.4.1 Brazil
    • 12.4.2 Argentina
    • 12.4.3 Rest of South America
  • 12.5 Middle East & Africa
    • 12.5.1 Kingdom of Saudi Arabia
    • 12.5.2 United Arab Emirates
    • 12.5.3 Rest of Middle East & Africa

13. Company Profiles

  • 13.1 Asahi Group Holdings, Ltd.
    • 13.1.1 Company details
    • 13.1.2 Financial outlook
    • 13.1.3 Product summary
    • 13.1.4 Recent developments
  • 13.2 Bayer AG
    • 13.2.1 Company details
    • 13.2.2 Financial outlook
    • 13.2.3 Product summary
    • 13.2.4 Recent developments
  • 13.3 Bio Veda Action Research Co.
    • 13.3.1 Company details
    • 13.3.2 Financial outlook
    • 13.3.3 Product summary
    • 13.3.4 Recent developments
  • 13.4 Blackmores
    • 13.4.1 Company details
    • 13.4.2 Financial outlook
    • 13.4.3 Product summary
    • 13.4.4 Recent developments
  • 13.5 BY-HEALTH Co., Ltd.
    • 13.5.1 Company details
    • 13.5.2 Financial outlook
    • 13.5.3 Product summary
    • 13.5.4 Recent developments
  • 13.6 Clinic Health Pvt. Ltd
    • 13.6.1 Company details
    • 13.6.2 Financial outlook
    • 13.6.3 Product summary
    • 13.6.4 Recent developments
  • 13.7 Clinique Laboratories, LLC
    • 13.7.1 Company details
    • 13.7.2 Financial outlook
    • 13.7.3 Product summary
    • 13.7.4 Recent developments
  • 13.8 FANCL Corp.
    • 13.8.1 Company details
    • 13.8.2 Financial outlook
    • 13.8.3 Product summary
    • 13.8.4 Recent developments
  • 13.9 Femarelle
    • 13.9.1 Company details
    • 13.9.2 Financial outlook
    • 13.9.3 Product summary
    • 13.9.4 Recent developments
  • 13.10 Garden of Life (Nestle)
    • 13.10.1 Company details
    • 13.10.2 Financial outlook
    • 13.10.3 Product summary
    • 13.10.4 Recent developments
  • 13.11 GNC Holdings Inc.
    • 13.11.1 Company details
    • 13.11.2 Financial outlook
    • 13.11.3 Product summary
    • 13.11.4 Recent developments
  • 13.12 Grape King Bio Ltd.
    • 13.12.1 Company details
    • 13.12.2 Financial outlook
    • 13.12.3 Product summary
    • 13.12.4 Recent developments
  • 13.13 Guardian.in
    • 13.13.1 Company details
    • 13.13.2 Financial outlook
    • 13.13.3 Product summary
    • 13.13.4 Recent developments
  • 13.14 Herbalife International of America Inc.
    • 13.14.1 Company details
    • 13.14.2 Financial outlook
    • 13.14.3 Product summary
    • 13.14.4 Recent developments
  • 13.15 INJA WELLNESS LLP
    • 13.15.1 Company details
    • 13.15.2 Financial outlook
    • 13.15.3 Product summary
    • 13.15.4 Recent developments
  • 13.16 Minimalist
    • 13.16.1 Company details
    • 13.16.2 Financial outlook
    • 13.16.3 Product summary
    • 13.16.4 Recent developments
  • 13.17 Nature's Bounty Co.
    • 13.17.1 Company details
    • 13.17.2 Financial outlook
    • 13.17.3 Product summary
    • 13.17.4 Recent developments
  • 13.18 Neemli
    • 13.18.1 Company details
    • 13.18.2 Financial outlook
    • 13.18.3 Product summary
    • 13.18.4 Recent developments
  • 13.19 Nu Skin Enterprise, Inc.
    • 13.19.1 Company details
    • 13.19.2 Financial outlook
    • 13.19.3 Product summary
    • 13.19.4 Recent developments
  • 13.20 Organic Harvest
    • 13.20.1 Company details
    • 13.20.2 Financial outlook
    • 13.20.3 Product summary
    • 13.20.4 Recent developments
  • 13.21 OZiva
    • 13.21.1 Company details
    • 13.21.2 Financial outlook
    • 13.21.3 Product summary
    • 13.21.4 Recent developments
  • 13.22 Pfizer Inc.
    • 13.22.1 Company details
    • 13.22.2 Financial outlook
    • 13.22.3 Product summary
    • 13.22.4 Recent developments
  • 13.23 Pharmavite LLC
    • 13.23.1 Company details
    • 13.23.2 Financial outlook
    • 13.23.3 Product summary
    • 13.23.4 Recent developments
  • 13.24 Revital Ltd.
    • 13.24.1 Company details
    • 13.24.2 Financial outlook
    • 13.24.3 Product summary
    • 13.24.4 Recent developments
  • 13.25 Standard Foods Corp.
    • 13.25.1 Company details
    • 13.25.2 Financial outlook
    • 13.25.3 Product summary
    • 13.25.4 Recent developments
  • 13.26 Suntory Holdings Ltd.
    • 13.26.1 Company details
    • 13.26.2 Financial outlook
    • 13.26.3 Product summary
    • 13.26.4 Recent developments
  • 13.27 Swisse Wellness Pty. Ltd
    • 13.27.1 Company details
    • 13.27.2 Financial outlook
    • 13.27.3 Product summary
    • 13.27.4 Recent developments
  • 13.28 Taisho Pharmaceutical Co. Ltd.
    • 13.28.1 Company details
    • 13.28.2 Financial outlook
    • 13.28.3 Product summary
    • 13.28.4 Recent developments
  • 13.29 The Derma Co
    • 13.29.1 Company details
    • 13.29.2 Financial outlook
    • 13.29.3 Product summary
    • 13.29.4 Recent developments
  • 13.30 The Himalaya Drug Company
    • 13.30.1 Company details
    • 13.30.2 Financial outlook
    • 13.30.3 Product summary
    • 13.30.4 Recent developments
  • 13.31 The Nature's Bounty Co
    • 13.31.1 Company details
    • 13.31.2 Financial outlook
    • 13.31.3 Product summary
    • 13.31.4 Recent developments
  • 13.32 Truebasics.com
    • 13.32.1 Company details
    • 13.32.2 Financial outlook
    • 13.32.3 Product summary
    • 13.32.4 Recent developments
  • 13.33 USANA Health Sciences, Inc.
    • 13.33.1 Company details
    • 13.33.2 Financial outlook
    • 13.33.3 Product summary
    • 13.33.4 Recent developments
  • 13.34 Vita Life Sciences
    • 13.34.1 Company details
    • 13.34.2 Financial outlook
    • 13.34.3 Product summary
    • 13.34.4 Recent developments